Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Share-based Compensation for 7 consecutive years, with $6.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 32.52% year-over-year to $6.5 million; the trailing twelve-month figure through Jun 2026 stood at $30.0 million (down 13.46% YoY), and the FY2025 full-year result was $33.8 million, up 10.52% from the prior year.
• Share-based Compensation slipped to $6.5 million in Q2 2026 per TMCI's latest filing, from $8.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $9.6 million in Q2 2025 and bottomed at $1.4 million in Q1 2022.
• Historically, Share-based Compensation has averaged $6.0 million across 5 years, with a median of $6.7 million in 2024.
• The widest YoY moves for Share-based Compensation: up 250.5% in 2022, down 76.86% in 2022.
• Over 5 years, Share-based Compensation stood at $2.3 million in 2022, then surged by 159.28% to $5.9 million in 2023, then jumped by 45.42% to $8.6 million in 2024, then retreated by 11.69% to $7.6 million in 2025, then fell by 14.45% to $6.5 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $6.5 million, $8.0 million, and $7.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.